Screening for EGFR Amplifications with a Novel Method and Their Significance for the Outcome of Glioblastoma Patients-Reference-Cited by-同舟云学术

Screening for EGFR Amplifications with a Novel Method and Their Significance for the Outcome of Glioblastoma Patients

Published:2013-06-06 Issue:6 Volume:8 Page:e65444
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Bieńkowski Michał,Piaskowski Sylwester,Stoczyńska-Fidelus Ewelina,Szybka Małgorzata,Banaszczyk Mateusz,Witusik-Perkowska Monika,Jesień-Lewandowicz Emilia,Jaskólski Dariusz J.,Radomiak-Załuska Anna,Jesionek-Kupnicka Dorota,Sikorska Beata,Papierz Wielisław,Rieske Piotr,Liberski Paweł P.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference42 articles.

1. Genetic pathways to primary and secondary glioblastoma. Am J Pathol;H Ohgaki,2007

2. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial;R Stupp;Lancet,2009

3. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med;R Stupp,2005

4. Cilengitide in patients with recurrent glioblastoma: the results of NABTC 03–02, a phase II trial with measures of treatment delivery. J Neurooncol;MR Gilbert,2012

5. Prognostic significance of molecular markers and extent of resection in primary glioblastoma patients. Clin Cancer Res;J Felsberg,2009

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunohistochemical detection of EGFRvIII in glioblastoma – Anti-EGFRvIII antibody validation for diagnostic and CAR-T purposes;Biochemical and Biophysical Research Communications;2023-12

2. Understanding the molecular profiling of diffuse gliomas classification: A brief overview;Surgical Neurology International;2023-06-30

3. The role of complete exomic sequencing in the administration of targeted drugs in patients with multiform glioblastoma;Head and Neck Tumors (HNT);2023-06-01

4. Effectiveness and safety of tumor-treating fields therapy for glioblastoma: A single-center study in a Chinese cohort;Frontiers in Neurology;2023-01-09

5. Radiotherapy Plus Temozolomide With or Without Nimotuzumab Against the Newly Diagnosed EGFR-Positive Glioblastoma: A Retrospective Cohort Study;The Oncologist;2022-10-01